Loading...
How I manage frontline transplant-ineligible multiple myeloma
The Multiple Myeloma (MM) is a plasma cells hematological malignancy with a median age of 69 years at diagnosis. The autologous stem cell transplantation is the standard of care for this disease but less than half of newly diagnosed patients are assessed for this treatment due to comorbidities or co...
Na minha lista:
| Udgivet i: | Hematol Rep |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
PAGEPress Publications, Pavia, Italy
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520858/ https://ncbi.nlm.nih.gov/pubmed/33042505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2020.8956 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|